| Literature DB >> 21864393 |
Volker Rudat1, Mohamed Hammoud, Yogin Pillay, Abdul Aziz Alaradi, Adel Mohamed, Saleh Altuwaijri.
Abstract
PURPOSE: The purpose of the study was to evaluate the patient set-up error of different anatomical sites, to estimate the effect of different frequencies of online verifications on the patient set-up accuracy, and to calculate margins to accommodate for the patient set-up error (ICRU set-up margin, SM). METHODS AND MATERIALS: Alignment data of 148 patients treated with inversed planned intensity modulated radiotherapy (IMRT) or three-dimensional conformal radiotherapy (3D-CRT) of the head and neck (n = 31), chest (n = 72), abdomen (n = 15), and pelvis (n = 30) were evaluated. The patient set-up accuracy was assessed using orthogonal megavoltage electronic portal images of 2328 fractions of 173 planning target volumes (PTV). In 25 patients, two PTVs were analyzed where the PTVs were located in different anatomical sites and treated in two different radiotherapy courses. The patient set-up error and the corresponding SM were retrospectively determined assuming no online verification, online verification once a week and online verification every other day.Entities:
Mesh:
Year: 2011 PMID: 21864393 PMCID: PMC3201019 DOI: 10.1186/1748-717X-6-101
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Patient set-up error (mm) for each scenario in three dimensions
| Direction | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AP | Lateral | SI | ||||||||
| Anatomical region | FOV | M | Σ | σ | M | Σ | σ | M | Σ | σ |
| Head and Neck | 0% | 0.3 | 0.9 | 1.6 | -0.3 | 1.3 | 1.6 | 0.6 | 1.5 | 2.2 |
| Chest | 0% | 0.7 | 2.4 | 2.7 | -0.3 | 2.2 | 2.7 | 0.5 | 1.7 | 2.4 |
| Abdomen | 0% | 0.6 | 3.0 | 3.3 | -0.9 | 2.4 | 3.0 | -0.8 | 3.6 | 3.1 |
| Pelvis | 0% | 0.9 | 2.3 | 3.2 | -0.3 | 1.8 | 2.7 | 1.0 | 3.2 | 2.5 |
| Head and Neck | 20% | 0.2 | 0.8 | 1.4 | -0.3 | 1.1 | 1.4 | 0.4 | 1.1 | 1.9 |
| Chest | 20% | 0.5 | 1.7 | 2.2 | -0.3 | 1.7 | 2.4 | 0.3 | 1.4 | 2.1 |
| Abdomen | 20% | 0.6 | 2.3 | 3.1 | -0.5 | 1.6 | 2.7 | -0.4 | 2.6 | 3.0 |
| Pelvis | 20% | 0.6 | 1.7 | 2.9 | -0.4 | 1.5 | 2.4 | 0.9 | 2.6 | 2.3 |
| Head and Neck | 50% | 0.1 | 0.5 | 1.1 | -0.1 | 0.6 | 1.2 | 0.2 | 0.6 | 1.3 |
| Chest | 50% | 0.3 | 0.9 | 1.6 | -0.2 | 1.1 | 2.0 | 0.2 | 0.8 | 1.6 |
| Abdomen | 50% | 0.4 | 1.5 | 2.5 | -0.2 | 1.1 | 2.5 | -0.4 | 1.7 | 2.8 |
| Pelvis | 50% | 0.5 | 1.3 | 2.4 | -0.2 | 1.1 | 1.9 | 0.6 | 1.4 | 2.0 |
Abbreviations: M = Overall population mean set-up error; Σ = Population systematic error; σ = Population random error; AP = anteroposterior; SI = superoinferior; FOV = Frequency of online verifications; 0% = No online verification; 20% = Online verification once a week; 50% = Online verification every other day.
Figure 1Frequency of set-up errors larger than threshold (three-dimensional vector) for all scenarios and all fractions. The frequency of online verifications is plotted on the horizontal axis (0%, no online verification; 20%, online verification once a week; 50%, online verification every other day), and the percentage of fractions with set-up errors larger than 3 mm, 5 mm or 10 mm on the vertical axis.
Figure 2Interindividual variability of frequencies of set-up errors larger than 5 mm (three-dimensional vector). The frequency of online verifications is plotted on the horizontal axis (0%, no online verification; 20%, online verification once a week; 50%, online verification every other day), and the percentage of fractions with set-up errors larger 5 mm on the vertical axis.
Set-up margins (mm) for each scenario using the van Herk formula [3]
| Safety Margin* | ||||
|---|---|---|---|---|
| Anatomical region | FOV | AP | Lateral | SI |
| Head and Neck | 0% | 3 | 4 | 5 |
| Chest | 0% | 7 | 7 | 5 |
| Abdomen | 0% | 9 | 8 | 11 |
| Pelvis | 0% | 8 | 6 | 9 |
| Head and Neck | 20% | 2 | 3 | 3 |
| Chest | 20% | 5 | 5 | 4 |
| Abdomen | 20% | 7 | 5 | 8 |
| Pelvis | 20% | 6 | 5 | 7 |
| Head and Neck | 50% | 1 | 2 | 2 |
| Chest | 50% | 3 | 3 | 2 |
| Abdomen | 50% | 5 | 4 | 6 |
| Pelvis | 50% | 4 | 3 | 4 |
Abbreviations: * = 95% of the dose for 90% of the patients; other abbreviations as in Table 1.